Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
wbl
on Dec 14, 2017
|
parent
|
context
|
favorite
| on:
Haemophilia A trial results 'mind-blowing'
The issue in Type 1 Diabetes is autoimmune destruction of the islets of Langerhans, so the therapy would need to target the immune system.
Consider applying for YC's Fall 2025 batch! Applications are open till Aug 4
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search:
